Laetitia Schwab
InvestorPrincipal at SR One Capital Management · Board director at Addition Therapeutics
London
Find your path to Laetitia
686 people in our graph share verified history with Laetitia — schools, employers, funds. One of them is your warm intro.
Sofia DolfeunlockedLaetitia: together at The University of Edinburgh (2009–2012)
×3Laetitia: together at GSK
×6Laetitia: together at University of Cambridge
Laetitia: together at SR One Capital Management
About
Laetitia Schwab is a Principal at SR One in the London office, joining in 2022. She previously worked in clinical development at Orchard Therapeutics, contributing to the delivery of the gene therapy Libmeldy for Marketing Authorisation, and has experience across early and late-phase clinical programs with expertise in gene therapy, neuroscience, and rare diseases. She holds a B.Sc in Medical Sciences from the University of Edinburgh, an MPhil in Translational Medicine and a Ph.D in Clinical Neuroscience from the University of Cambridge, and an MBA from INSEAD.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Addition Therapeutics
Intro paths
→
In turn, Laetitia can intro founders to Addition Therapeutics's investors below.
Addition Therapeutics's investors · 4
Co-founders at Addition Therapeutics
KC
Kathleen CollinsDirector
Experience
- SR One Capital ManagementPrincipalcurrent2026 — presentLondon, England, United Kingdom
- SR One Capital ManagementSenior Associate2024 — 2026London Area, United Kingdom
- SR One Capital ManagementAssociate2022 — 2026London Area, United Kingdom
- Draig TherapeuticsBoard Membercurrent2025 — present
- Addition TherapeuticsBoard Membercurrent2025 — present
- Avenzo TherapeuticsBoard Observercurrent2022 — present
- Sofinnova PartnersVenture Capital MBA Intern2021
- Orchard TherapeuticsSenior Clinical Development Scientist2019 — 2020London, United Kingdom
- Orchard TherapeuticsClinical Development Scientist2017 — 2018London, United Kingdom
- GSKClinical Development Intern, Rare disease unit2016London, Royaume-Uni
- GlaxoSmithKlineClinical Development Intern, Rare Disease Unit2012GSK House, London
- Sanofi Pasteur MSDClinical Development Trainee2011Région de Lyon, France
Skills & more
Pharmaceutical Industry14Microsoft Excel9Research11Neuroscience10Microsoft Office3Clinical Development5Clinical Research5Clinical Trials7Healthcare ConsultingConsulting2Life Sciences1
Languages English · French · Spanish
- Future VC Summer 2021 — Future VC
From Laetitia's professional profile.
Investments
Board seats
Per SEC Form D filings.
Colleagues at SR One Capital Management
Alicia Hasson
Executive Assistant at SR One Capital Management
Amit Mehta
Venture Partner - US Investments at SR One Capital Management
Amit Shah
Principal at SR One Capital Management
Ann Ng
Finance Director at SR One Capital Management
Brian Gallagher
Partner at SR One Capital Management
Briana Wilson
Senior Administrative Assistant at SR One Capital Management
Catalina Kazi
Legal & Compliance Counsel at SR One Capital Management
Chris Chai
Operating Partner - Portfolio Capital Raising at SR One Capital Management
Frequently asked questions
- Who is Laetitia Schwab?
- Laetitia Schwab is a Principal at SR One in the London office, joining in 2022. She previously worked in clinical development at Orchard Therapeutics, contributing to the delivery of the gene therapy Libmeldy for Marketing Authorisation, and has experience across early and late-phase clinical programs with expertise in gene therapy, neuroscience, and rare diseases. She holds a B.Sc in Medical Sciences from the University of Edinburgh, an MPhil in Translational Medicine and a Ph.D in Clinical Neuroscience from the University of Cambridge, and an MBA from INSEAD.
- Where does Laetitia Schwab work?
- Laetitia Schwab is Principal at SR One Capital Management and Board director at Addition Therapeutics.
- What does Laetitia Schwab invest in?
- Laetitia Schwab invests in Biotech.
- What boards does Laetitia Schwab sit on?
- Laetitia Schwab holds tracked board seats at Addition Therapeutics.
- Where did Laetitia Schwab go to school?
- Laetitia Schwab studied at INSEAD (Master of Business Administration - MBA, Business Administration and Management); University of Cambridge (Doctor of Philosophy (PhD), Clinical Neuroscience); University of Cambridge (Master of Philosophy (MPhil), Clinical Science: Translational Medicine and Therapeutics).
Same school
Also attended INSEAD1,220
Alexandre ProtCo-founder & CEO of QontoSteve AnaviCo-founder & President of QontoPatrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index Ventures
+ 1,214 more
Also attended University of Cambridge1,492
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosFounder and Managing Partner of VerdictGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 1,486 more
Shared employers
Also worked at SR One Capital Management32
Freya Svedberg-KeatingInvestor at MedicxiJake BauerVenture Partner at ARCH Venture PartnersAleks Radovic-MorenoPartner at Longwood FundVikas GoyalPartner at Longwood FundSimeon J. GeorgeFounder & CEO at SR One Capital ManagementRajeev DadooCOO & Managing Partner at SR One Capital Management
+ 26 more
Also worked at Draig Therapeutics4
Also worked at Sofinnova Partners77
Anne HorganPartner at Cambridge Innovation CapitalAntoine Papiernik PapiernikChairman and Managing Partner at Sofinnova PartnersGraziano SeghezziManaging Partner at Sofinnova PartnersMichael KrelPartner at Sofinnova PartnersHenrijette RichterManaging Partner at Sofinnova PartnersZhizhong YaoPartner at Sofinnova Partners
+ 71 more
